Resolute System    

Log In

Forgot Your Password?

Not a member? Click here!

One-Year Outcomes in 1010 Unselected Patients Treated with the PROMUS Element Everolimus-Eluting Stent: The Multicenter PROMUS Element European Post-Approval Surveillance Study
First Report on the Pivotal DESolve Nx trial: 6-month Clinical and Multimodality Imaging Results
Two-year clinical outcomes in the EVOLVE FHU trial
Carotid, Brachiocephalic and Intracranial Vascular Anatomy: What the Interventionalist Needs to Know



Racial Disparities in CABG Patients

Black patients undergoing CABG may have worse outcomes than their white counterparts. A comparison of 11,697 black and 136,363 white patients undergoing CABG has indicated that black patients tend to be younger, have greater comorbidities and adverse presenting features. Unadjusted mortality and morbidity were greater in black patients and these persisted after adjustment for surgeon, hospital and care processes.

For more, click here




Predictors of IMA Failure

The internal mammary artery (IMA) is the conduit of choice for the left anterior descending (LAD) artery. Data on the frequency and predictors of IMA failure are sparse. Data from the PREVENT IV study have shown that IMA failure occurred in 8.6% of patients with predictors of such failure being LAD stenosis <75%, additional bypass graft to diagonal branches, and absence of diabetes. IMA failure was associated with increased rates of repeat revascularization.

For more, click here



Long-Term Benefits of Bariatric Surgery

The long-term benefits of bariatric surgery are uncertain. A study of 242 adolescents undergoing Roux-en-Y gastric bypass or sleeve gastrectomy over a period of 3 years has demonstrated that that procedure led to a 27% reduction in weight, 95% remission in type 2 diabetes, 86% remission of abnormal kidney function, 74% remission of hypertension, and 66% remission of dyslipidemia. Iron deficiency was identified in 57% of the participants, and 13% required one or more additional procedures.

For more, click here




Port of Entry in Infective Endocarditis

Data regarding the port of microbial entry leading to infective endocarditis are scarce. In a study of 318 patients, the skin, oral or dental and the GI route were the three most common routes of entry accounting for 62%, 29%, and 23% of case, respectively. Intravenous drug use, dental infection colonic polys and colorectal adenocarcinoma were among common sources of infection in each category.

For more, click here



Catheter-Based Therapies for Patients with Medication-Refractory Pulmonary Hypertension
- Dr. Jane A. Leopold, MD
Arterial Conduits in Coronary Artery Bypass Grafting An Inconvenient Truth
- Mario Gaudino, MD
First-in-man Experience of the Transcatheter FORMA Repair System for Treating Severe Tricuspid Regurgitation
- Francisco Campelo-Parada, MD
Selecting the Right FFR in an Unsteady State: Keep It Simple
- Morton Kern, MD
Transcatheter Structural Heart Interventions for the treatment of Chronic Heart Failure
- Dr Josep Rodes Cabau, MD
 Click here to visit the WEBEX archives
Complex Patients Today and Tomorrow: Medtronic DES solutions from Resolute Integrity to bioresorbable stents
Prof. Sigmund Silber, MD
First Report on the Pivotal DESolve Nx trial: 6-month Clinical and Multimodality Imaging Results
Alexandre Abizaid, MD, PhD
One-Year Outcomes in 1010 Unselected Patients Treated with the PROMUS Element Everolimus-Eluting Stent: The Multicenter PROMUS Element European Post-Approval Surveillance Study
Raul Moreno, MD, et al.
Two-year clinical outcomes in the EVOLVE FHU trial
Ian Meredith, MD, PhD
Stephan Windecker, MD, et al.

Durable Polymer DES: 5 Year Outcomes RESOLUTE Update
Sigmund Silber, MD
Evaluation of Two-Year Outcomes Following Resolute Integrity Zotarolimus-eluting Stent Implantation
Ronald Caputo, MD
Properties of a Novel Drug Filled Coronary Stent: Impact on Mechanical Strength and Radiopacity
Nicolas Foin, MSc, PhD
Titratable Drug Delivery from Drug-Filled Stents
Rami Tzafriri, MD
Outcomes in More Than 7000 Patients With Diabetes After Implantation of the Resolute Zotarolimus-eluting Stent
Rosli Mohd Ali, MD
Safety update and long-term clinical outcomes from all studies in the RESOLUTE Global Clinical Program
Carlo Di Mario, MD
Final Five-year Outcomes from the Randomized Comparison of Zotarolimus-eluting Stents With Everolimus-eluting Stents in the RESOLUTE All Comers Trial
Stephan Windecker, MD
Angina Status & TLF Creep: Bioabsorbable Stents (BAS) & Drug-Eluting Stents (DES)
Medtronic, Inc.
Clinical outcomes associated with dual antiplatelet therapy interruption following implantation of the ResoluteTM zotarolimus-eluting stent
Stephan Windecker, MD
Four-year Outcomes from the Randomized Comparison of a Zotarolimus-eluting and an Everolimus-eluting Stent in the RESOLUTE All Comers Trial
Patrick W Serruys MD, PhD
Resolute in Bifurcation Lesions: Data from the RESOLUTE Clinical Program
Prof. Ran Kornowski, MD

Untitled Document
Sex Versus Gender-Related Characteristics. Which Predicts Outcome After Acute Coronary Syndrome in the Young?
R Pelletier, et al.
JACC 2016; 67:127-135
Utility of Nontraditional Risk Markers in Atherosclerotic Cardiovascular Disease Risk Assessment.
J Yeboah, et al.
JACC 2016; 67:139-147
Systematic Search for Present and Potential Portals of Entry for Infective Endocarditis.
F Delahaye, et al.
JACC 2016; 67: 151-158
Association of Hospital and Physician Characteristics and Care Processes With Racial Disparities in Procedural Outcomes Among Contemporary Patients Undergoing Coronary Artery Bypass Grafting Surgery.
R Mehta, et al.
Circ 2016; 133:124-130
Frequency and Predictors of Internal Mammary Artery Graft Failure and Subsequent Clinical Outcomes. Insights From the Project of Ex-vivo Vein Graft Engineering via Transfection (PREVENT) IV Trial.
R Harskamp, et al.
Circ 2016; 133:131-138
Pathobiological Determinants of Atherosclerosis in Youth (PDAY) Risk Score in Young Adults Predicts Coronary Artery and Abdominal Aorta Calcium in Middle Age. The CARDIA Study.
S Gidding, et al.
Circ 2016; 133:139-146
Weight Loss and Health Status 3 Years after Bariatric Surgery in Adolescents.
T Inge, et al.
NEJM 2016; 374:113-123
Plasma Urate Concentration and Risk of Coronary Heart Disease: A Mendelian Randomisation Analysis.
J White, et al.
The Lancet Diabetes & Endocrinology 2016 Online
Use of Coronary Computed Tomographic Angiography Findings to Modify Statin and Aspirin Prescription in Patients With Acute Chest Pain.
A Pursnani, et al.
AJC 2016; 117:319-324
Clinical Profiles Related to Timing of Death, Including In-Hospital Deaths Before Admission, in Patients With ST-Elevation Myocardial Infarction.
P Bogaty, et al.
AJC 2016; 17:347-352
Ambulatory Heart Rate Range Predicts Mode-Specific Mortality and Hospitalisation in Chronic Heart Failure.
Cubbon, et al.
Heart 2016; 102:223-229
Association Between Pre-Operative Statin Use and Major Cardiovascular Complications Among Patients Undergoing Non-Cardiac Surgery: The VISION Study.
O Berwanger, et al.
EHJ 2016; 37:177-185

Poll Archives

Marc P. Bonaca, MD, MPH
Mark J. Eisenberg, M.D
Justin A. Ezekowitz, M.D
Myeong-Ki Hong, MD. PhD
DAPT Study
Robert W. Yeh, M.D
A Network Meta-Analysis
Michael J. Lipinski, M.D
Mark Crowther, MD, MSc, FRCPC
Gender Disparities - TAVR
Michael A. Gaglia, Jr., M.D
Geeta Gulati1, M.D
The Impact of Prior Stroke on the Outcome of Patients with Severe Aortic Stenosis Undergoing TAVR
Romain Didier, M.D
The PCSK9 Inhibitor Revolution
Norman E. Lepor, MD, FACC
Paul K. Whelton, MB, MD, MSc

The ABSORB III trial
Dean J. Kereiakes, MD
ABSORB China Trial
Run-Lin Gao, MD
Bernard Chevalier, MD
Michael Haude, MD
Giora Weisz, MD
Jose PS Henriques, MD
TOTAL: One-Year Outcomes
Sanjit S. Jolly, MD
Effect of Thrombus Aspiration in Patients With Myocardial Infarction Presenting Late After Symptom Onset
Steffen Desch, MD
Mark A. Hlatky, MD
Philip M. Urban, MD
Tuxedo: One Year Clinical Results
Upendra Kaul, MD
Bo Xu, MD
IN.PACT SFA: Two-Year Outcomes
John Laird, MD
Thierry Lefevre, MD
SAPIEN 3: One-Year Outcomes
Howard C. Herrmann, MD
John D. Carroll
Evaluation of Initial Surgical Versus Conservative Strategies in Patients With Asymptomatic Severe Aortic Stenosis:
Tomohiko Taniguchi, MD
1-Year Results from the PARTNER II Valve-in-Valve Registry
Danny Dvir, MD
1 year results of the TOTAL trial
TOTAL Investigators
RevElution Clinical Trial
Stephen G. Worthley, MBBS, PhD
CoreValve Data
Jeffrey J. Popma, MD
TWENTE Five-Year Outcomes
Clemens von Birgelen, MD, PhD
The Nordic-Baltic Bifurcation Study III
Matti Niemela, MD
Cheol Woong Yu1, MD, PhD
Pivotal Trial
James B. Hermiller Jr, MD
Neointimal Modification with Scoring-Balloon and Efficacy of Drug-Coated Balloon Therapy in Patients with Restenosis in Drug-Eluting Coronary Stents
Robert A. Byrne, MD
Alignment of DNR Status with Patients Likelihood of Favorable Neurological Survival after In-hospital Cardiac Arrest
Timothy Fendler, MD, MS
A serial multivessel OCT study
Lorenz Raber, MD, MS

Live Case Demonstration from Kusatsu Heart Center
Osamu Hatoh, MD
Treating CTO via Radial?
Richard R. Heuser, MD
Patient Selection for CTO Recanalization: What Are the Appropriate Criteria?
Tarek Helmy, MD
Treating CTOs: Is There Enough Evidence-Based Data or do We Need Further Randomized Clinical Trials?
Gerald S. Werner, MD, PhD
Indication for CTO PCI: Clinical Rationale and Appropriateness
J. Aaron Grantham, MD

CE Mark Approved for Vivasure Medical’s Fully Bioabsorbable Percutaneous Closure Device for Large-Bore Transcatheter Procedures

SurModics Acquires NorMedix

Teleflex Acquires Nostix to Expand Catheter Tip Placement Solutions

First Implant Completed in Thoracoabdominal Aortic Aneurysm Clinical Study of Gore Excluder Device

CE Mark Approved for Medtronic’s In.Pact Admiral DCB to Treat AV Access in Hemodialysis Patients

Contego Medical’s Paladin Carotid Postdilation Balloon System Launched in Europe

Micell Technologies Announces Completion of Enrollment in MiStent Randomized Trial Against Xience

Boston Scientific Receives FDA Approval And CE Mark For AngioJet™ ZelanteDVT™ Thrombectomy Catheter

Praxbind® (idarucizumab) approved in European Union for the specific reversal of Pradaxa® (dabigatran etexilate)

Toshiba America Medical Systems and Ziehm Imaging Inc. Partner to Give Healthcare Providers Best-In-Class Fixed and Mobile C-arm Technology

Surefire Medical Closes $15M Series C Financing Led by Tullis Health Investors

MedStar Heart & Vascular Institute Granted an IDE to Initiate a Transcatheter Aortic Valve Replacement Study for Patients With Symptomatic Aortic Stenosis at Low Risk for Surgical Mortality


FDA Approves COBRA-REDUCE Trial for CeloNova’s Cobra PzF Stent System

Miracor Medical Systems Launches PICSO Impulse System in Asia

St. Jude Medical’s 27-mm and 29-mm Portico TAVR Valves Gain CE Mark Approval

pToWin Assesses Phenox’s pConus Bifurcation Aneurysm Device in Wide-Neck Intracranial Aneurysms

CE mark for 27mm and 29mm of Portico TAVI valves

First Patient Enrolled in Phase 4 of AUGUSTUS Trial to Evaluate Safety of Eliquis

Valtech’s Cardioband Mitral Reconstruction System Receives CE Mark Approval for TMVR

US FDA approves expanded indication for BRILINTA to include long-term use in patients with a history of heart attack

Proteon Therapeutics Announces Top-Line Results From Phase 1 Study of Investigational Drug Vonapanitase in Patients With Symptomatic Peripheral Artery Disease
Angiomyogenesis & Cell Therapy
Carotid Interventions

Home | CRT2015 | CardioTube | Interesting Cases | Trials | Weekly Poll Archive | Newsletter Archive | Login

Copyright © 2016, CRTONLINE - About / Contact Us. All rights reserved. Privacy Policy
Powered by Multiweb